We deliver powerful, reliable tools that fuel scientific discoveries and drive exponential progress to master biology to advance human health. Our innovative single cell, spatial, and in situ technologies enable discoveries across oncology, immunology, neuroscience, and more. Our team has created innovative instruments, reagents, and software that analyze biological systems at a resolution that matches the complexity of biology.

The Institut de recherche contre les cancers de l’Appareil digestif (IRCAD), based in Strasbourg, France, was founded in 1994 by Professor Jacques Marescaux with the mission of creating a unique research and training institute dedicated to minimally invasive surgery IRCAD+1. Its purpose is to combine scientific research with advanced surgical education to advance the field of surgery globally.

Kyowa Kirin is a global pharmaceutical company committed to developing innovative therapeutic solutions for patients with rare diseases. Our commitment to patients is reflected in a constant drive to address unmet medical needs and improve the management of rare and complex conditions.

Building on our expertise spanning clinical research, development, and treatment delivery, we leverage our scientific and technological capabilities across several therapeutic areas, notably X-linked hypophosphatemia (XLH), tumor-induced osteomalacia (TIO), and cutaneous T-cell lymphoma (CTCL).

Further information is available on our website: https://www.kyowakirinhub.com/en-gb/ [ou en-us selon votre cible]

National Institute on Aging: NIA has been a Platinum sponsor of the Vitamin D Workshops since 2014 in the form of a Scientific Meeting Grant (R13AG048689) entitled “Annual Vitamin D Workshops. Funding for this conference was made possible, in part, by R13 AG48689-01 from the National Institute on Aging. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention by trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

The OSCAR network (Rare Diseases of Bone, Calcium, and Cartilage) is a French national healthcare network dedicated to improving the diagnosis, care, and treatment of rare skeletal and metabolic conditions. Funded by the French Ministry of Health, it unites expert hospital centers, research labs, and patient advocacy groups.

The Journal of Steroid Biochemistry and Molecular Biology is a peer-reviewed scientific journal that covers all aspects of steroid metabolism, including experimental and theoretical developments in areas such as vitamin D, lipids, and metabolomics

It publishes a variety of contributions, including original research articles, general and focused reviews, and rapid communications that highlight novel findings. The journal also features Special Issues managed by guest editors, which include commissioned reviews and invited original research to provide comprehensive coverage of specific topics